跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 15,275 条关于
“PROS”
全部
15,275
临床试验
10,696
药物
360
机构
58
资讯
4,161
2年前
Telisotuzumab Vedotin Improves Patient-Reported Outcomes in c-Met+ NSCLC
去年
FDA Issues Draft Guidance on Patient-Reported Outcomes in Cancer Clinical Trials
去年
LUMINOSITY Trial: Telisotuzumab Vedotin Shows Promising Patient-Reported Outcomes in c-Met+ NSCLC
去年
BriaCell Receives $2 Million NCI Grant to Advance Personalized Prostate Cancer Immunotherapy
3个月前
EMA Grants Conditional Approval for Vijoice, First Treatment for Rare PIK3CA-Related Overgrowth Disorders
去年
Quality of Life Measures Gain Critical Importance in Gynecologic Oncology Care
7个月前
ICR Develops First Standardized Guidelines for Patient-Reported Outcomes in Early Cancer Drug Trials
去年
Phase 3 Trial of Opevesostat vs. NHA Switch in Metastatic Castration-Resistant Prostate Cancer
去年
Patient-Reported Outcomes and Real-World Data Reshape Treatment Landscape in CLL and MCL
去年
Proteomic and Polygenic Profiling Enhances Colorectal Cancer Risk Stratification
第 1 页,共 417 页
上一页
下一页